News
Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...
In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...
6d
The Brighterside of News on MSNNew synthetic molecule targets and kills breast and pancreatic cancers in as few as three dosesScientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...
Passion is an important word in Georgina Long’s lexicon. It’s the drive that has stamped her as an internationally renowned ...
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University ...
Lehigh Valley Topper Cancer Institute, part of Lehigh Valley Health Network, announced last week the opening of the region’s only clinical trial for an immunotherapeutic pancreatic cancer vaccine. Dr ...
After Decades Without Progress in Glioblastoma, Diakonos Stirs up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
SHANGHAI, China I July 4, 2025 I Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing ...
The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...
The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.
Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...
Cedars-Sinai investigators led an update of staging guidelines for HPV-positive throat cancer—now more common in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results